Quest Diagnostics acquires Blueprint GeneticsChristian Fernsby ▼ | January 22, 2020
Quest Diagnostics today announced that it has acquired Blueprint Genetics in an all-cash equity transaction.
Acquisition Quest Diagnostics
Topics: Quest Diagnostics acquire Blueprint Genetics
Together, Quest and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development.
Financial terms of the transaction were not disclosed. ■